TDC
RCPI

Thompson Davis & Co’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Thompson Davis & Co’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-80
Closed – – 1361
2015
Q2 		$0 Hold
80
– – ﹤0.01% 1345
2015
Q1 		$0 Hold
80
– – ﹤0.01% 1354
2014
Q4 		$0 Hold
80
– – ﹤0.01% 1357
2014
Q3 		$1K Sell
80
-80
-50% -$790 ﹤0.01% 1127
2014
Q2 		$2K Buy
+160
New +$2.78K ﹤0.01% 736

Other funds holding RCPI

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Thompson Davis & Co's RCPI Position: Q3 2015 in Review

Thompson Davis & Co sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q3 2015, closing a stake of 80 shares.

Thompson Davis & Co first reported a position in RCPI in Q2 2014 and held it in 5 quarters. The position peaked at $2K in Q2 2014. 37 funds tracked by Wall St. Rank hold RCPI as of Q3 2015.

  • Thompson Davis & Co reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q3 2015 after selling out during the quarter.
  • Thompson Davis & Co sold 80 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q3 2015.
  • Thompson Davis & Co first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 5 quarters.
  • Thompson Davis & Co's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $2K in Q2 2014.
  • 37 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q3 2015.

Based on Thompson Davis & Co's 13F filing for Q3 2015, filed 30 Oct 2015.